Share on LinkedInShare on LinkedIn

ARTICLE · 18 AUGUST 2020

Price Gouging Weekly Round Up - August 17, 2020

Proskauer Rose LLP
Proskauer Rose LLP
Contributor
Proskauer Rose LLP

Proskauer Rose LLP

Firm Overview Proskauer is an elite global law firm with more than 900 lawyers across key financial...

View firm profile
Explore more from Proskauer Rose LLP

Price gouging enforcement and litigation is front and center for company counsel and business managers nationwide.

United StatesCoronavirus (COVID-19)

Price gouging enforcement and litigation is front and center for company counsel and business managers nationwide. Our weekly round up highlights some of the most relevant news and information to our clients and friends.

Bipartisan Effort in the Senate to Target Price Gouging

A recent bipartisan Senate bill—the Make Medications Affordable by Preventing Pandemic Price-gouging (MMAPPP) Act—was introduced by Oregon's Jeff Merkley and Minnesota's Tina Smith, and is also co-sponsored by California's Kamala Harris, New York's Kirsten Gillibrand, and Wisconsin's Tammy Baldwin. Similar to the house bill introduced in June, the Senate bill focuses on ensuring that taxpayer-funded vaccines and treatments for COVID-19, and future diseases, are financially accessible. The MMAPPP would: (1) prohibit exclusive licensing of new, taxpayer-funded drugs that are used to diagnose, mitigate, prevent, or treat COVID-19 in order to ensure universal access to the drugs; (2) require

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from